PTHrP stimulates osteoblasts to express RANKL, which in turn promotes osteoclast formation and bone resorption which further releases growth factors like TGF-β and stimulate cancer growth and the production of osteolytic factors, including PTHrP (Guise and Chirgwin, 2003). This evidence concerns the gene TGFB1 and cancer.